FDA Alert: Counterfeit Ozempic found in U.S. Supply Chain

April 15, 2025

The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the U.S. drug supply chain. The falsified products, labeled with lot number PAR0362 and serial numbers beginning with 51746517, were seized by the FDA on April 9, 2025. Their contents and safety are unverified and pose serious health risks.

[...]

Handout: Illegal ingredients linked to knockoff weight loss drugs pouring in from foreign sources

March 26, 2025

Compounded versions of GLP-1 injectable treatments for diabetes and obesity have surged in popularity despite a lack the safety and efficacy assurances. The FDA has warned that these knockoff versions sometimes contain illicit semaglutide or tirzepatide—the active pharmaceutical ingredients (APIs) in weight loss drugs. Working with George Karavetsos, former director of FDA’s Office of Criminal…

[...]

Compounded weight loss injections — knock-offs are not the same

February 7, 2025
Still from ad that says "Knock off drugs aren't worth the risk"

Compounded weight loss injections — knock-offs are not the same Who says legally-compounded versions are not as safe as the FDA-approved products? The Food and Drug Administration. In November 2024, the Food and Drug Administration (FDA) issued “Compounding and the FDA: Questions and Answers,” warning that Compounded drugs should only be used in patients whose…

[...]